2 comments

[ 3.7 ms ] story [ 20.7 ms ] thread
TL;DR: "In conclusion, individuals who have laboratory-confirmed symptomatic SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination, and vaccines can be safely prioritized to those who have not been infected before."